IP Verse

Process For Making Dry And Stable Hemostatic Compositions - EP2575770

The patent EP2575770 was granted to Baxter on Mar 22, 2017. The application was originally filed on Jun 1, 2011 under application number EP11724603A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2575770

BAXTER
Application Number
EP11724603A
Filing Date
Jun 1, 2011
Status
Granted And Under Opposition
Feb 17, 2017
Grant Date
Mar 22, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ETHICONDec 22, 2017CARPMAELS & RANSFORDADMISSIBLE
FERROSAN MEDICAL DEVICESDec 20, 2017HOIBERG PSADMISSIBLE

Patent Citations (26) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO03000785
DESCRIPTIONWO03007845
DESCRIPTIONWO9808550
EXAMINATIONUS2002082620
INTERNATIONAL-SEARCH-REPORTUS2003224056
INTERNATIONAL-SEARCH-REPORTUS6391343
INTERNATIONAL-SEARCH-REPORTWO0197871
OPPOSITIONEP0172710
OPPOSITIONEP1543842
OPPOSITIONEP1649867
OPPOSITIONUS2002082620
OPPOSITIONUS2003224056
OPPOSITIONUS2006002918
OPPOSITIONUS2008109002
OPPOSITIONUS2558395
OPPOSITIONUS4655211
OPPOSITIONUS6361551
OPPOSITIONUS6391343
OPPOSITIONUS6706690
OPPOSITIONWO0197871
OPPOSITIONWO02072128
OPPOSITIONWO2005002510
OPPOSITIONWO2009109963
OPPOSITIONWO9013320
OPPOSITIONWO9808550
OPPOSITIONWO9831403

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Floseal instructions for use", Floseal Hemostatic Matrix, (20150406), pages 1 - 7, XP055447311-
OPPOSITION- "FloSeal Matrix Hemostatic Sealant", Biomedical Engineering Seminar, (20011015), URL: http://www.ele.uri.edu/Courses/bme281/F01/LeeAnn_1.pdf, XP055449124-
OPPOSITION- Fusion Medical Technologies, Inc., "Summary of Safety and Effectiveness of FloSealTM Hemostatic Sealant", FDA, (19991208), pages 7 - 19, URL: https://www.accessdata.fda.gov/cdrh_docs/pdf/P990009B.pdf, XP055449131-
OPPOSITION- SCHREIBER et al., "Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings", AORN Journal, (20111100), vol. 94, no. 5, pages S1 - S20, XP028329409
OPPOSITION- LEWIS et al., "Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model", J Investigative Surgery, (20130000), vol. 26, pages 141 - 148, XP055447306

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents